NCT04021979

Brief Summary

This clinical trial is being conducted to assess whether dietary restriction with enteral nutrition prescribed could prevent nonadherence to dietary restrictions, enable additional reduction of the required volume of PEG-ELS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
248

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 5, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
16 days until next milestone

Study Start

First participant enrolled

August 1, 2019

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2019

Completed
Last Updated

July 16, 2019

Status Verified

July 1, 2019

Enrollment Period

Same day

First QC Date

July 5, 2019

Last Update Submit

July 14, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • the quality of bowel preparation

    Evaluation of the quality of bowel preparation for each participant by the Ottawa bowel preparation scale(OBPS),it's a validated scoring system with scores between 0 and 14, where 0 is the best score,The score comprises a sub score 0-4 for each colon segment: right, transverse and rectosigmoid colon.n addition, a score 0-2 is added to indicate the total amount of luminal fluid.

    1day

Secondary Outcomes (5)

  • patients' satisfaction with the process of bowel preparation

    1day

  • patients' willingness to have the colonoscopy done again at this facility in the future

    1day

  • comparison with previous experience

    1day

  • adverse events

    1day

  • Convenience of Protocol between enteral nutrition with low volume 1.5L PEG and Self-controlled diet with normal amount of 2L PEG Protocol

    1day

Study Arms (2)

Enteral Nutritional+PEG

EXPERIMENTAL

Enteral Nutritional Powder with low volume 1.5L PEG

Dietary Supplement: Enteral Nutrition Powder EnsureDrug: 1.5L PEG

Self-controlled diet+PEG

PLACEBO COMPARATOR

Self-controlled diet with normal amount of 2L PEG

Other: Self-controlled dietDrug: 2L PEG

Interventions

Enteral Nutrition Powder Ensure for each meal.The duration of study is one day before colonoscopy.

Also known as: Ensure
Enteral Nutritional+PEG

Low volume PEG

Also known as: Hengkangzhengqing
Enteral Nutritional+PEG

Self-controlled low residue diet.

Self-controlled diet+PEG
2L PEGDRUG

Normal volume of PEG

Also known as: Hengkangzhengqing
Self-controlled diet+PEG

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the age of 18-75year
  • Outpatients undergoing colonoscopy
  • Informed consent

You may not qualify if:

  • the age \>75 years or \<18 years
  • history of colectomy or bowel obstruction
  • severe constipation (defined as stool frequerncy of 3 or less/week)
  • current pregnancy or breastfeeding
  • BMI \>30, diabetes
  • known allergies to cleansing agents or ingredients of Enteral nutrition
  • inability to follow the oral bowel preparation regimen.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ningbo first hospital

Ningbo, Zhejiang, 315010, China

Location

Study Officials

  • Hongpeng Lu, master

    Department of Gastroenterology, Ningbo No. 1 Hospital, Ningbo, China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 5, 2019

First Posted

July 16, 2019

Study Start

August 1, 2019

Primary Completion

August 1, 2019

Study Completion

November 1, 2019

Last Updated

July 16, 2019

Record last verified: 2019-07

Data Sharing

IPD Sharing
Will not share

Locations